本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Olema Pharmaceuticals, Inc.

4.17
+0.11002.71%
盘后4.170.00000.00%19:33 EDT
成交量:94.25万
成交额:388.33万
市值:2.85亿
市盈率:-2.14
高:4.20
开:3.96
低:3.89
收:4.06
数据加载中...
2021/08/10

重要事件披露

8-K - Current report
2021/08/10

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/06/09

重要事件披露

8-K - Current report
2021/05/11

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/05/11

重要事件披露

8-K - Current report
2021/04/06

重要事件披露

8-K - Current report
2021/03/17

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/03/17

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/03/17

重要事件披露

8-K - Current report
2021/02/16

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/04

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/12/03

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2020/11/23

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/11/23

重要事件披露

8-K - Current report
2020/11/20

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2020/11/19

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2020/11/16

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2020/10/30

招股说明书

S-1 - General form for registration of securities under the Securities Act of 1933